About Quanterix
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.
|
|
|
201-500 employees
View all Quanterix employees
|
|
Biotechnology
|
|
900 Middlesex Tpke, Billerica, Massachusetts 01821, US
|
|
2007
|
|
Oncology, Biomarkers, Proteomics, Diagnostics, Neurology, Assays, Digital Elisa, Ultrasensitive Immunoassay
|
Quanterix Alternatives
Frequently Asked Questions about Quanterix
Frank Guo is the CEO of Quanterix. To contact Frank Guo email at [email protected], [email protected] or [email protected]. Or you may call 13901839623
The decision makers in Quanterix are Bruce Bal, Francois Falco, Fred Carter, etc. Click to Find Quanterix decision makers emails.
Quanterix Staff Directory
Search Quanterix Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
